Literature DB >> 2462597

A 230-kD basic protein is the major bullous pemphigoid antigen.

S Mueller1, V Klaus-Kovtun, J R Stanley.   

Abstract

Recent studies have demonstrated that bullous pemphigoid (BP) antigen, in extracts of cultured human keratinocytes and normal human epidermis, is a 230-kD polypeptide. However, other recent studies have suggested that there is heterogeneity of BP antigen at the molecular level. To demonstrate that this 230-kD polypeptide is the major BP antigen and to further characterize it, we tested multiple BP sera by both immunoprecipitation of extracts of radiolabeled cultured human keratinocytes and immunoblotting of extracts of normal human epidermis. Thirty-six of 37 BP sera immunoprecipitated the 230-kD polypeptide, and 11 of 13 BP sera identified the 230-kD polypeptide by immunoblotting. Eighty-six disease and normal control sera did not bind the 230-kD BP antigen. Immunoprecipitation was a more sensitive assay than was immunoblotting to detect the 230-kD antigen; BP sera that were weak or negative by immunoblotting were strongly positive by immunoprecipitation. To demonstrate that this 230-kD polypeptide shared epitopes, defined by BP sera, with the epidermal basement membrane zone, we showed that BP IgG affinity purified on this polypeptide bound the epidermal basement membrane zone by immunofluorescence. To further characterize the BP antigen and to compare the antigen synthesized by cultured human keratinocytes to the antigen extracted from epidermis, we analyzed the 230-kD BP antigen by two-dimensional gel electrophoresis. BP antigen immunoprecipitated from culture extracts or BP antigen identified by immunoblots of epidermal extracts was a single spot on two-dimensional gels, with a pI of about 8. These data indicate that, although other polypeptides are sometimes identified (e.g., a 166 kD band by immunoprecipitation or a 180 kD band on immunoblots), the major BP antigen identified in cultured human keratinocytes is similar to the antigen found in normal human epidermis and is a basic 230-kD polypeptide.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2462597     DOI: 10.1111/1523-1747.ep13070476

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  26 in total

1.  Production of human monoclonal anti-basement membrane zone (BMZ) antibodies from a patient with bullous pemphigoid (BP) by Epstein-Barr virus transformation. Analyses of the heterogeneity of anti-BMZ antibodies in BP sera using them.

Authors:  T Sugi; T Hashimoto; T Hibi; T Nishikawa
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

2.  Widespread dermal ulcerations and bullae.

Authors:  Jay Wofford; Mahir Patel; Allison Readinger; Alan Menter
Journal:  Proc (Bayl Univ Med Cent)       Date:  2012-04

Review 3.  Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.

Authors:  J R Stanley
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

Review 4.  Bullous pemphigoid: from bench to bedside.

Authors:  Scott R A Walsh; David Hogg; P Régine Mydlarski
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Identification of two collagen domains within the bullous pemphigoid autoantigen, BP180.

Authors:  G J Giudice; H L Squiquera; P M Elias; L A Diaz
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

6.  Genetic alterations at the Bpag1 locus in dt mice and their impact on transcript expression.

Authors:  Madeline Pool; Céline Boudreau Larivière; Gilbert Bernier; Kevin G Young; Rashmi Kothary
Journal:  Mamm Genome       Date:  2005-12-08       Impact factor: 2.957

7.  Bullous pemphigoid and rheumatoid arthritis: is there disease association?

Authors:  S M Sant; S O'Loughlin; G M Murphy
Journal:  Ir J Med Sci       Date:  1997 Apr-Jun       Impact factor: 1.568

Review 8.  Spectraplakin family proteins - cytoskeletal crosslinkers with versatile roles.

Authors:  Jamie Zhang; Jiping Yue; Xiaoyang Wu
Journal:  J Cell Sci       Date:  2017-07-05       Impact factor: 5.285

9.  The human 230-kD bullous pemphigoid antigen gene (BPAG1). Exon-intron organization and identification of regulatory tissue specific elements in the promoter region.

Authors:  K Tamai; D Sawamura; H C Do; Y Tamai; K Li; J Uitto
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

10.  Periplakin gene targeting reveals a constituent of the cornified cell envelope dispensable for normal mouse development.

Authors:  Sirpa Aho; Kehua Li; Young Ryoo; Clair McGee; Akemi Ishida-Yamamoto; Jouni Uitto; John F Klement
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.